COAGULATION FACTOR VIIA RECOMBINANT HUMAN

COAGULATION FACTOR VIIA RECOMBINANT HUMAN was reported 93 times

COAGULATION FACTOR VIIA RECOMBINANT HUMAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FACTOR VIII ACTIVITY DECREASED 3 0.1304
1 FACTOR VII INHIBITION 1 0.0667
2 ANTI FACTOR IX ANTIBODY INCREASED 1 0.0556
3 ANTI FACTOR IX ANTIBODY POSITIVE 1 0.0435
4 PECTUS CARINATUM 1 0.0278
5 PLASMA CELLS DECREASED 1 0.0200
6 ANTI FACTOR VIII ANTIBODY INCREASED 2 0.0161
7 ANTI FACTOR VIII ANTIBODY POSITIVE 7 0.0124
8 TESTICULAR HAEMORRHAGE 1 0.0114
9 COMPLICATED APPENDICITIS 1 0.0085
10 BILIARY NEOPLASM 1 0.0081
11 EAR TUBE INSERTION 1 0.0034
12 TRANSFUSION-RELATED ACUTE LUNG INJURY 1 0.0032
13 GASTROENTERITIS ROTAVIRUS 1 0.0032
14 GASTROENTERITIS BACTERIAL 1 0.0030
15 PROTHROMBIN LEVEL INCREASED 1 0.0029
16 ADENOIDECTOMY 1 0.0026
17 HAEMOBILIA 1 0.0024
18 BODY HEIGHT INCREASED 1 0.0020
19 DEVICE RELATED THROMBOSIS 2 0.0020
20 FACTOR VIII INHIBITION 2 0.0019
21 HAEMATOMA INFECTION 1 0.0017
22 PELVIC VENOUS THROMBOSIS 2 0.0014
23 LIMB ASYMMETRY 1 0.0013
24 KLEBSIELLA SEPSIS 1 0.0009
25 ARTERIAL HAEMORRHAGE 1 0.0009
26 HAEMATOMA MUSCLE 1 0.0008
27 STEROID DIABETES 1 0.0007
28 NEOPLASM SKIN 1 0.0006
29 INHIBITORY DRUG INTERACTION 1 0.0006
30 POST PROCEDURAL HAEMATOMA 1 0.0006
31 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
32 CEREBELLAR INFARCTION 1 0.0006
33 MUSCLE HAEMORRHAGE 2 0.0005
34 EAR HAEMORRHAGE 1 0.0005
35 URINARY BLADDER HAEMORRHAGE 1 0.0005
36 RENAL TUBULAR ACIDOSIS 1 0.0005
37 HAEMARTHROSIS 4 0.0004
38 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
39 PULMONARY INFARCTION 1 0.0004
40 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
41 RETROPERITONEAL HAEMORRHAGE 1 0.0004
42 CATHETER SITE HAEMORRHAGE 1 0.0004
43 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
44 SERUM SICKNESS 1 0.0004
45 MULTIPLE-DRUG RESISTANCE 1 0.0003
46 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
47 FACE INJURY 1 0.0003
48 RHINOVIRUS INFECTION 1 0.0003
49 PRODUCT DISPENSING ISSUE 1 0.0002
50 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
51 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
52 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
53 INTERMENSTRUAL BLEEDING 1 0.0002
54 SKIN WARM 1 0.0002
55 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
56 HAEMATOMA 4 0.0002
57 HAEMORRHAGE INTRACRANIAL 2 0.0001
58 SHOCK HAEMORRHAGIC 1 0.0001
59 ESCHERICHIA INFECTION 1 0.0001
60 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
61 GROIN PAIN 1 0.0001
62 MYOSITIS 1 0.0001
63 UROSEPSIS 1 0.0001
64 HAEMORRHAGE 11 0.0001
65 THROMBOTIC MICROANGIOPATHY 1 0.0001
66 SUBARACHNOID HAEMORRHAGE 1 0.0001
67 WEIGHT FLUCTUATION 1 0.0001
68 MELAENA 2 0.0001
69 THERAPY NON-RESPONDER 4 0.0001
70 POST PROCEDURAL HAEMORRHAGE 1 0.0001
71 CHOLECYSTITIS 1 0.0001
72 TOOTH EXTRACTION 1 0.0001
73 LIMB INJURY 2 0.0001
74 MASS 1 0.0001
75 HYPOKINESIA 1 0.0001
76 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
77 HIP ARTHROPLASTY 1 0.0001
78 DEVICE RELATED INFECTION 1 0.0001
79 HEAD INJURY 2 0.0001
80 CYTOMEGALOVIRUS INFECTION 1 0.0001
81 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
82 INJURY ASSOCIATED WITH DEVICE 1 0.0000
83 PRODUCT PRESCRIBING ISSUE 1 0.0000
84 PRODUCT AVAILABILITY ISSUE 1 0.0000
85 PNEUMONIA ASPIRATION 1 0.0000
86 HAEMATEMESIS 1 0.0000
87 NO ADVERSE EVENT 7 0.0000
88 RESPIRATORY TRACT INFECTION 1 0.0000
89 JOINT STIFFNESS 1 0.0000
90 EAR INFECTION 1 0.0000
91 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
92 TREATMENT NONCOMPLIANCE 2 0.0000
93 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
94 ANAPHYLACTIC REACTION 2 0.0000
95 FEELING COLD 1 0.0000
96 HAEMOPTYSIS 1 0.0000
97 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
98 ACUTE MYOCARDIAL INFARCTION 1 0.0000
99 PULMONARY EMBOLISM 3 0.0000
100 CYSTITIS 1 0.0000
101 RASH MACULAR 1 0.0000
102 HYPOXIA 1 0.0000
103 HYPERGLYCAEMIA 1 0.0000
104 RESTLESSNESS 1 0.0000
105 EPISTAXIS 2 0.0000
106 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
107 EXTRA DOSE ADMINISTERED 1 0.0000
108 RECTAL HAEMORRHAGE 1 0.0000
109 VAGINAL HAEMORRHAGE 1 0.0000
110 INTENTIONAL PRODUCT MISUSE 2 0.0000
111 OFF LABEL USE 20 0.0000
112 COVID-19 4 0.0000
113 CONTUSION 2 0.0000
114 DRUG INEFFECTIVE 26 0.0000
115 HAEMOGLOBIN DECREASED 2 0.0000
116 ARTHROPATHY 1 0.0000
117 LETHARGY 1 0.0000
118 DISCOMFORT 1 0.0000
119 FEBRILE NEUTROPENIA 1 0.0000
120 INJURY 1 0.0000
121 BRONCHITIS 1 0.0000
122 DIABETES MELLITUS 1 0.0000
123 INJECTION SITE SWELLING 1 0.0000
124 THROMBOSIS 1 0.0000
125 FALL 4 0.0000
126 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
127 RENAL IMPAIRMENT 1 0.0000
128 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
129 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
130 CARDIAC DISORDER 1 0.0000
131 GAIT DISTURBANCE 2 0.0000
132 DRUG INTOLERANCE 1 0.0000
133 INFLUENZA 1 0.0000
134 THROMBOCYTOPENIA 1 0.0000
135 WEIGHT INCREASED 2 0.0000
136 PYREXIA 3 0.0000
137 OEDEMA PERIPHERAL 1 0.0000
138 LOSS OF CONSCIOUSNESS 1 0.0000
139 PRODUCT QUALITY ISSUE 1 0.0000
140 INFECTION 1 0.0000
141 PERIPHERAL SWELLING 1 0.0000
142 TREMOR 1 0.0000
143 URTICARIA 1 0.0000
144 CEREBROVASCULAR ACCIDENT 1 0.0000
145 HYPERSENSITIVITY 1 0.0000
146 PRODUCT USE ISSUE 1 0.0000
147 ABDOMINAL PAIN UPPER 1 0.0000
148 DEPRESSION 1 0.0000
149 INCORRECT DOSE ADMINISTERED 1 0.0000
150 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
151 WEIGHT DECREASED 1 0.0000
152 CONDITION AGGRAVATED 1 0.0000
153 ARTHRALGIA 1 0.0000
154 RASH 1 0.0000
155 VOMITING 1 0.0000
156 HEADACHE 1 0.0000
157 NAUSEA 1 0.0000
158 DEATH 1 0.0000